Get notified when OSTX files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsStanding Risk Factors
- Going Concern (unchanged) — The auditor's report includes a going concern warning, indicating doubt about the company's ability to continue operating.
OS Therapies launches at-the-market offering of up to $75M, with shares priced at $1.58
Filed August 21, 2026 · ~1 min read
Key Changes
-
high
The company may sell up to $75 million of common stock through an at-the-market facility with Jefferies, with no minimum amount guaranteed.
The Offering verify on EDGAR → -
high
Net proceeds from the offering are estimated at $2.5 million, after underwriting discounts and expenses, based on the $1.58 per share price.
Use of Proceeds verify on EDGAR → -
high
New investors face immediate dilution of $0.98 per share, as pro forma net tangible book value is only $0.60 per share after the offering.
Dilution verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (MKC 10-Q) is open in full — no account needed.
Partner
Trade OSTX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Aug 31, 2026 · How we verify